Dr. V. N. Balaji

Dr. Balaji received his Ph.D in Molecular Biophysics in 1981 from Indian Institute of Science, Bangalore, India. He did his Post-doctoral research at Department of Chemistry, Rutgers University, New Jersey, USA (1981-83). He has over 29 years of pharmaceutical industrial experience (from molecular design to scientific management). He worked at Lederle Laboratories (Pearl River, NY, USA), Allergan Pharmaceuticals (Irvine, CA, USA), Immuno Pharmaceuticals (San Diego, CA, USA), Monsanto (St. Louis, Missouri, USA and R&D Centre, Bangalore, India) and Jubilant Biosys (Bangalore, India). In 2001, he co-founded Jubilant Biosys, Bangalore, India and mentored to establish state-of-the-art drug discovery laboratory including informatics, high throughput screening, molecular design, structural biology, invitro and invivo biology, DMPK etc. Jubilant Biosys established several international collaboration and successfully delivered drug discovery projects. He has co-authored more than 40 publications and 20 patents. He contributed to the molecular design of the anti-acne drug “Tazaroc” marketed by Allergan Pharmaceuticals. He initiated Endothelin antagonist programme at Immuno Pharmaceuticals and contributed to the molecular design of anti-hypertensive drug “Thelin”. At Jubilant Biosys he mentored several drug discovery collaboration initiatives. He is a member of more than 8 national and international organizations including Confederation of Indian Industry (CII). He is a member of Editorial Advisory Board -Chemical Biology & Drug Design.